Key Statistics
Market Cap$46.20M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$4.04
52W High$19.35
52W Low$3.76
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees13
Price Performance
1 Week+13.67%
3 Month-42.05%
1 Year-44.33%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$96.25M
Liabilities$5.24M
Net Income$30.09M loss
About
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs in the areas of oncology and infectious diseases. The company is headquartered in Seattle, Washington.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze ATOS with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.
